首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
AntineoplasticsHepatitis B reactivation: 3 case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2021年
/ 1840卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-021-90181-2
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:38 / 38
相关论文
共 50 条
[41]
DaratumumabHepatitis B reactivation: case report
Reactions Weekly,
2024,
2037
(1)
: 149
-
149
[42]
CarfilzomibHepatitis B reactivation: case report
Reactions Weekly,
2019,
1782
(1)
: 94
-
94
[43]
ThalidomideHepatitis B reactivation: case report
Reactions Weekly,
2008,
1200
(1)
: 29
-
29
[44]
RuxolitinibHepatitis B reactivation: case report
Reactions Weekly,
2022,
1923
(1)
: 440
-
440
[45]
RituximabHepatitis B reactivation: case report
Reactions Weekly,
2014,
1494
(1)
: 40
-
40
[46]
AdalimumabHepatitis B reactivation: case report
Reactions Weekly,
2016,
1586
(1)
: 20
-
20
[47]
RituximabHepatitis B reactivation: case report
Reactions Weekly,
2017,
1672
(1)
: 238
-
238
[48]
ImmunosuppresantsHepatitis B reactivation: case report
Reactions Weekly,
2022,
1893
(1)
: 181
-
181
[49]
RituximabHepatitis B reactivation: case report
Reactions Weekly,
2023,
1946
(1)
: 491
-
491
[50]
RituximabHepatitis B reactivation: case report
Reactions Weekly,
2009,
1261
(1)
: 27
-
28
←
1
2
3
4
5
→